Alector
The Senior Director, Clinical Development will lead the clinical strategy for the AL137 program as it enters Phase 1 trials, providing medical leadership on protocol design, safety, dose escalation, and data interpretation. This role partners with Clinical Operations, Translational Medicine, Regulatory, Safety, Biometrics, and other functions to drive patient‑centered decisions and integrate emerging technologies, including AI, into the development process.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2013
Alector is a biopharmaceutical company focused on discovering and developing therapies for neurodegenerative diseases. The company applies neuroimmunology — harnessing the immune system and genetic insights — to target the underlying biology driving brain disorders. Alector advances programs from discovery into clinical development with the goal of slowing or stopping neurodegeneration and improving patient outcomes.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alector.
Senior Clinical Lead, Early Clinical & Experimental Therapeutics
sanofi us
Director, Oncology Translational Medicine, Clinical Biomarkers
GSK plc
Medical Director, Early Clinical Development London ( hybrid role 2 days per week onsite)
biomarin
Senior or Executive Medical Director
Iambic Therapeutics
Early Clinical Trial Physician
Bristol Myers Squibb
Contract Remote Medical Director
Clinical Dynamix